1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.
Copyright © 2015 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Values are presented as mean±standard deviation. Statistics were analyzed by the Mann-Whitney U test. ΔMeans the difference between the numbers of SDSCA items before and after the use of the application. ΔVariables (day/wk)=after use of application (day/wk)-before use of application (day/wk).
aStatistically significant differences (P<0.05).
Characteristic | Value |
---|---|
Sex, male/female | 71 (78.9)/19 (21.1) |
Age, yr | |
Mean±SD | 43.5±10.5 |
Median (range) | 44.0 (14-74) |
Duration of diabetes, yr | |
<1 | 33 (36.7) |
1 to <3 | 18 (20.0) |
3 to <5 | 12 (13.3) |
5 to <10 | 11 (12.2) |
≥10 | 16 (17.8) |
Period of 'Diabetes Notepad' application usage | |
<6 mo | 73 (82.0) |
6 mo to <1 yr | 13 (14.6) |
≥1 yr | 3 (3.4) |
Smartphone model | |
iPhone | 12 (13.3) |
Android phone | 78 (86.7) |
Education level | |
Primary school | 2 (2.2) |
Junior high school | 1 (1.1) |
High school | 15 (16.7) |
University or higher | 72 (80.0) |
Income/mo (Korean won) | |
≤1,000,000 | 15 (16.9) |
1,010,000-2,000,000 | 13 (14.6) |
2,010,000-3,000,000 | 15 (16.9) |
3,010,000-5,000,000 | 25 (28.1) |
≥5,010,000 | 21 (23.6) |
Comorbidities | |
None | 38 (56.7) |
Hypertension | 13 (19.4) |
Dyslipidemia | 12 (17.9) |
Other | 4 (6.0) |
Strongly agree | Agree | Disagree | Strongly disagree | |
---|---|---|---|---|
Have there been positive changes in the clinical course of diabetes after the use of the application? | 22 (24.7) | 52 (58.4) | 14 (15.7) | 1 (1.1) |
Are you satisfied with the structure and completeness of the application? | 28 (31.1) | 50 (55.6) | 12 (13.3) | 0 |
Is the application easy to use? | 44 (48.9) | 43 (47.8) | 3 (3.3) | 0 |
Are you willing to actively recommend the application to others? | 48 (53.3) | 40 (44.4) | 2 (2.2) | 0 |
Will you keep using the application to manage diabetes? | 62 (69.7) | 24 (27.0) | 2 (2.2) | 1 (1.1) |
Characteristic | Have there been positive changes in the clinical course of diabetes after the use of the application? | Are you satisfied with the structure and completeness of the application? | Is the application easy to use? | Are you willing to actively recommend the application to others? | Will you keep using the application to manage diabetes? |
---|---|---|---|---|---|
Sex | |||||
Male (n=71) | 3.08±0.69 | 3.20±0.62 | 3.54±0.50 | 3.55±0.56 | 3.70±0.55 |
Female (n=19) | 3.00±0.59 | 3.11±0.74 | 3.16±0.69 | 3.37±0.50 | 3.44±0.71 |
P value | 0.556 | 0.642 | 0.026a | 0.144 | 0.106 |
Age, yr | |||||
<40 (n=28) | 3.00±0.68 | 3.18±0.72 | 3.46±0.58 | 3.61±0.50 | 3.63±0.63 |
≥40 (n=62) | 3.10±0.67 | 3.18±0.62 | 3.45±0.56 | 3.47±0.56 | 3.66±0.57 |
P value | 0.477 | 0.914 | 0.905 | 0.299 | 0.951 |
Duration of diabetes, yr | |||||
<1 (n=33) | 3.06±0.72 | 3.24±0.66 | 3.61±0.50 | 3.58±0.50 | 3.63±0.55 |
1 to <3 (n=18) | 3.11±0.76 | 3.11±0.68 | 3.28±0.58 | 3.50±0.62 | 3.67±0.77 |
3 to <5 (n=12) | 3.00±0.74 | 2.92±0.29 | 3.25±0.45 | 3.33±0.65 | 3.58±0.52 |
5 to <10 (n=11) | 3.00±0.63 | 3.18±0.60 | 3.55±0.52 | 3.36±0.50 | 3.55±0.69 |
≥10 (n=16) | 3.13±0.50 | 3.31±0.79 | 3.44±0.73 | 3.63±0.50 | 3.81±0.40 |
P value | 0.961 | 0.411 | 0.177 | 0.564 | 0.634 |
Period of 'Diabetes Notepad' application usage | |||||
<6 mo (n=73) | 3.07±0.65 | 3.16±0.66 | 3.46±0.55 | 3.50±0.56 | 3.60±0.62 |
6 mo to <1 yr (n=13) | 3.15±0.80 | 3.23±0.60 | 3.46±0.66 | 3.62±0.51 | 3.92±0.28 |
≥1 yr (n=3) | 2.67±0.58 | 3.33±0.58 | 3.33±0.58 | 3.33±0.58 | 3.67±0.58 |
P value | 0.484 | 0.89 | 0.888 | 0.658 | 0.158 |
Smartphone model | |||||
iPhone (n=12) | 3.00±0.85 | 2.92±0.52 | 3.33±0.49 | 3.50±0.67 | 3.67±0.65 |
Android phone (n=78) | 3.08±0.64 | 3.22±0.66 | 3.47±0.58 | 3.51±0.53 | 3.65±0.58 |
P value | 0.724 | 0.113 | 0.331 | 0.881 | 0.764 |
Education level | |||||
High school or lower (n=18) | 3.06±0.54 | 3.39±0.61 | 3.22±0.65 | 3.39±0.50 | 3.78±0.43 |
University or higher (n=72) | 3.07±0.70 | 3.13±0.65 | 3.51±0.53 | 3.54±0.56 | 3.62±0.62 |
P value | 0.835 | 0.121 | 0.077 | 0.22 | 0.366 |
Income/mo (Korean won) | |||||
≤1,000,000 (n=15) | 3.07±0.62 | 3.33±0.62 | 3.40±0.63 | 3.40±0.51 | 3.67±0.49 |
1,010,000-2,000,000 (n=13) | 2.92±0.50 | 2.77±0.73 | 3.15±0.69 | 3.46±0.52 | 3.46±0.66 |
2,010,000-3,000,000 (n=15) | 3.07±0.70 | 3.27±0.70 | 3.60±0.51 | 3.67±0.49 | 3.79±0.58 |
3,010,000-5,000,000 (n=25) | 3.08±0.69 | 3.19±0.69 | 3.50±0.51 | 3.50±0.65 | 3.46±0.71 |
≥5,010,000 (n=21) | 3.14±0.79 | 3.24±0.43 | 3.52±0.51 | 3.52±0.51 | 3.90±0.30 |
P value | 0.883 | 0.206 | 0.399 | 0.697 | 0.020a |
Comorbidities | |||||
None (n=38) | 3.12±0.67 | 3.18±0.62 | 3.48±0.57 | 3.54±0.57 | 3.63±0.64 |
Hypertension (n=13) | 3.15±0.69 | 3.23±0.73 | 3.31±0.63 | 3.54±0.52 | 3.69±0.48 |
Dyslipidemia (n=12) | 2.67±0.65 | 3.17±0.72 | 3.58±0.52 | 3.42±0.52 | 3.67±0.49 |
Other (n=4) | 3.25±0.50 | 3.00±0.82 | 3.25±0.50 | 3.25±0.50 | 3.75±0.50 |
P value | 0.141 | 0.943 | 0.556 | 0.591 | 0.993 |
Variable | Before, day | After, day | P value |
---|---|---|---|
Blood sugar testing | 3.60±2.67 | 5.53±1.78 | 0.000a |
Diet | 4.97±2.05 | 5.70±1.52 | 0.000a |
Alcohol | 1.26±1.69 | 1.07±1.71 | 0.054 |
Smoking | 2.31±3.16 | 1.80±2.83 | 0.002a |
Exercise | 2.67±2.14 | 3.78±2.23 | 0.000a |
Medication | 4.64±2.83 | 5.55±2.31 | 0.000a |
Weight measurement | 1.80±2.04 | 2.66±2.29 | 0.000a |
Comply with regular lifestyle | 3.61±2.15 | 5.00±1.94 | 0.000a |
ΔVariable | ΔBlood sugar testing | ΔDiet | ΔAlcohol | ΔSmoking | ΔExercise | ΔMedication | Δweight measurement | ΔComply with regular lifestyle |
---|---|---|---|---|---|---|---|---|
Sex | ||||||||
Male (n=71) | 2.26±2.89 | 0.73±1.58 | -0.20±1.77 | -0.66±1.80 | 1.33±2.21 | 0.86±2.23 | 0.99±1.49 | 1.68±1.96 |
Female (n=19) | 0.74±1.94 | 0.74±1.05 | -0.16±0.38 | 0.00±0.00 | 0.26±2.28 | 1.11±2.18 | 0.37±1.64 | 0.32±0.75 |
P value | 0.020a | 0.709 | 0.578 | 0.088 | 0.170 | 0.728 | 0.076 | 0.006a |
Age, yr | ||||||||
<40 (n=28) | 1.39±2.49 | 0.82±1.66 | 0.21±2.52 | -0.78±2.24 | 0.96±2.74 | 1.04±2.15 | 0.82±2.04 | 1.11±1.91 |
≥40 (n=62) | 2.18±2.89 | 0.69±1.40 | -0.37±0.85 | -0.40±1.26 | 1.16±2.03 | 0.85±2.25 | 0.87±1.26 | 1.52±1.84 |
P value | 0.113 | 0.936 | 0.285 | 0.948 | 0.600 | 0.892 | 0.271 | 0.198 |
Duration of diabetes, yr | ||||||||
<1 (n=33) | 2.30±3.32 | 0.76±1.64 | -0.15±2.46 | -1.00±2.22 | 1.94±2.72 | 1.61±2.57 | 0.85±1.87 | 1.58±2.09 |
1 to <3 (n=18) | 1.22±2.92 | 0.72±1.13 | -0.17±0.71 | -0.71±1.83 | 0.33±2.09 | 1.12±2.50 | 0.83±1.92 | 1.06±1.59 |
3 to <5 (n=12) | 1.91±2.39 | 0.00±1.13 | -0.50±1.00 | -0.08±0.29 | 0.64±1.36 | 0.17±0.94 | 1.00±1.13 | 1.17±1.64 |
5 to <10 (n=11) | 2.36±2.46 | 0.73±1.35 | -0.09±0.54 | 0.00±0.00 | 0.45±0.82 | 0.18±2.27 | 1.00±1.00 | 1.45±1.75 |
≥10 (n=16) | 1.69±1.78 | 1.25±1.69 | 1.25±1.69 | 0.00±0.00 | 1.00±2.19 | 0.27±1.03 | 0.69±0.79 | 1.50±2.00 |
P value | 0.723 | 0.492 | 0.875 | 0.195 | 0.585 | 0.206 | 0.860 | 0.945 |
Period of 'Diabetes Notepad' application usage | ||||||||
<6 mo (n=73) | 2.22±2.88 | 0.80±1.54 | -0.31±1.41 | -0.51±1.68 | 1.12±2.33 | 0.97±2.27 | 0.78±1.42 | 1.50±1.93 |
6 mo to <1 yr (n=13) | 0.42±1.83 | 0.38±1.21 | 0.31±2.39 | -0.69±1.44 | 1.08±2.02 | 0.69±2.10 | 1.38±2.18 | 0.92±1.32 |
≥1 yr (n=3) | 1.00±1.00 | 0.67±1.16 | 0.67±0.58 | 0.00±0.00 | 0.67±2.08 | 0.33±0.58 | 0.33±0.58 | 0.67±2.08 |
P value | 0.196 | 0.713 | 0.065 | 0.467 | 0.810 | 0.926 | 0.702 | 0.475 |
Smartphone model | ||||||||
iPhone (n=12) | 2.83±2.86 | 0.25±1.42 | -0.83±2.13 | -0.33±1.16 | 1.08±2.28 | 1.00±2.13 | 1.25±2.30 | 1.33±1.88 |
Android phone (n=78) | 1.79±2.76 | 0.81±1.48 | -0.09±1.47 | -0.55±1.68 | 1.10±2.27 | 0.89±2.23 | 0.79±1.39 | 1.40±1.87 |
P value | 0.242 | 0.286 | 0.161 | 0.681 | 0.576 | 0.935 | 0.670 | 0.775 |
Education level | ||||||||
High school or lower (n=18) | 1.17±1.98 | 0.61±1.09 | 0.06±2.10 | 0.00±0.00 | 0.83±1.76 | 0.29±1.05 | 0.28±1.45 | 1.00±1.85 |
University or higher (n=72) | 2.13±2.93 | 0.76±1.56 | -0.25±1.43 | -0.65±1.79 | 1.17±2.37 | 1.06±2.38 | 1.00±1.53 | 1.49±1.86 |
P value | 0.186 | 0.716 | 0.239 | 0.100 | 0.474 | 0.315 | 0.302 | 0.150 |
Income/mo (Korean won) | ||||||||
≤1,000,000 (n=15) | 0.67±1.95 | 0.87±1.25 | 0.47±1.81 | 0.00±0.00 | 0.07±2.69 | 0.93±1.91 | 0.47±1.64 | 0.40±1.21 |
1,010,000-2,000,000 (n=13) | 1.62±2.53 | 1.00±2.04 | -0.77±1.54 | -0.38±0.96 | 1.67±2.64 | 1.23±2.65 | 0.77±1.74 | 1.77±2.09 |
2,010,000-3,000,000 (n=15) | 3.13±2.85 | 1.47±1.89 | -0.07±2.02 | -1.67±2.94 | 2.53±3.16 | 1.93±2.71 | 1.47±1.92 | 2.20±2.78 |
3,010,000-5,000,000 (n=25) | 1.04±2.41 | 0.08±0.85 | -0.08±1.52 | -0.38±1.39 | 0.58±1.21 | 0.92±1.98 | 0.96±1.37 | 1.04±1.43 |
≥5,010,000 (n=21) | 3.35±3.10 | 0.76±1.30 | -0.52±0.98 | -0.30±1.13 | 1.14±1.35 | -0.10±1.68 | 0.62±1.61 | 1.71±1.52 |
P value | 0.003a | 0.049a | 0.146 | 0.225 | 0.185 | 0.127 | 0.411 | 0.067 |
Comorbidities | ||||||||
None (n=38) | 1.50±2.69 | 0.87±1.54 | -0.08±1.44 | -0.38±1.45 | 1.07±2.32 | 0.63±2.03 | 0.70±1.54 | 1.28±1.86 |
Hypertension (n=13) | 3.08±2.66 | 0.38±1.76 | -0.46±2.57 | -0.77±1.96 | 1.46±2.18 | 1.00±2.13 | 1.46±1.56 | 2.15±2.30 |
Dyslipidemia (n=12) | 2.75±2.99 | 0.50±0.67 | -0.42±1.17 | -0.83±2.13 | 1.17±2.48 | 2.00±2.76 | 1.08±1.62 | 0.75±0.75 |
Other (n=4) | 2.25±3.30 | 0.50±1.29 | -0.25±0.50 | -0.75±1.50 | 0.25±0.50 | 1.50±3.00 | 0.50±0.58 | 2.50±1.92 |
P value | 0.165 | 0.936 | 0.674 | 0.500 | 0.766 | 0.430 | 0.420 | 0.280 |
ΔVariable | Two groups according to the satisfaction with the application | P value | |
---|---|---|---|
Groups with high satisfaction with the application (n=53) | Groups with low satisfaction with the application (n=37) | ||
ΔBlood sugar testing | 2.43±2.77 | 1.19±2.66 | 0.024a |
ΔDiet | 0.85±1.66 | 0.57±1.17 | 0.781 |
ΔAlcohol | -0.23±1.67 | -0.14±1.46 | 0.249 |
ΔSmoking | -0.85±2.05 | -0.05±0.23 | 0.092 |
ΔExercise | 1.58±2.43 | 0.43±1.82 | 0.000a |
ΔMedication | 0.92±2.42 | 0.89±1.89 | 0.516 |
ΔWeight measurement | 1.21±1.83 | 0.35±0.72 | 0.003a |
ΔComply with regular lifestyle | 1.91±1.94 | 0.65±1.46 | 0.000a |
Values are presented as the number (%).
Values are presented as the number (%). Cronbach's α=0.791.
Values are presented as mean±standard deviation. Statistics were analyzed by the Mann-Whitney aStatistically significant differences (
Values are presented as mean±standard deviation. Statistics were analyzed by the Wilcoxon signed rank test. aStatistically significant differences (
Values are presented as mean±standard deviation. Statistics were analyzed by the Mann-Whitney aStatistically significant differences (
Values are presented as mean±standard deviation. Statistics were analyzed by the Mann-Whitney aStatistically significant differences (